Search

Your search keyword '"Olivier Espitia"' showing total 135 results

Search Constraints

Start Over You searched for: Author "Olivier Espitia" Remove constraint Author: "Olivier Espitia"
135 results on '"Olivier Espitia"'

Search Results

1. Vasodilator drugs and heart-related outcomes in systemic sclerosis: an exploratory analysis

2. Higher risk profile among patients with TET2-mutated giant cell arteritis: a cluster analysis

Catalog

Books, media, physical & digital resources

3. Risk of recurrence after discontinuing anticoagulation in patients with COVID-19- associated venous thromboembolism: a prospective multicentre cohort studyResearch in context

4. Development and validation of a quality of life measurement scale specific to hereditary hemorrhagic telangiectasia: the QoL-HHT

5. Intravenous versus subcutaneous tocilizumab in Takayasu arteritis: multicentre retrospective study

6. Thoracic lymphadenopathies in diffuse systemic sclerosis: an observational study on 48 patients using computed tomography

7. Inter and intra-observer agreement of arterial wall contrast-enhanced ultrasonography in giant cell arteritis

8. Specific features to differentiate Giant cell arteritis aortitis from aortic atheroma using FDG-PET/CT

9. Assessment of the efficacy and safety of tocilizumab in patients over 80 years old with giant cell arteritis

10. Symptomatic aortitis at giant cell arteritis diagnosis: a prognostic factor of aortic event

11. Risk factors for symptomatic vascular events in giant cell arteritis: a study of 254 patients with large-vessel imaging at diagnosis

12. Large-vessel involvement is predictive of multiple relapses in giant cell arteritis

13. Predictive factors of venous recanalization in upper-extremity vein thrombosis.

14. Long‐Term Outcome and Prognostic Factors of Complications in Thromboangiitis Obliterans (Buerger's Disease): A Multicenter Study of 224 Patients

15. Implication of molecular vascular smooth muscle cell heterogeneity among arterial beds in arterial calcification.

16. Clinical spectrum and outcome of Takayasu’s arteritis in children

17. Risk Factors of Venous Thromboembolic Disease in Cancer Patients Treated with Immune Checkpoint Inhibitor

18. Multiple concomitant arterial aneurysms in Behçet’s disease

20. Case–Control Study on Exercise-Induced Vasculitis in Hikers

21. Anti–programmed death ligand 1 immunotherapies in cancer patients with pre-existing systemic sclerosis: A postmarketed phase IV safety assessment study

22. Predictive factors of stent patency in iliofemoral venous diseases in a multicenter cohort study

23. Semi-Quantitative [

24. Relationship between histopathological features of non-infectious aortitis and the results of pre-operative 18F-FDG-PET/CT: a retrospective study of 16 patients

25. Antiphospholipid syndrome in patients over 65 years: A comparative study of clinical and biological features and thrombotic relapses

26. Refinement of a modified simplified Pulmonary Embolism Severity Index for elderly patients with acute pulmonary embolism

27. Étude monocentrique sur les médicaments pris par les patients pour le traitement de la sclérodermie systémique

29. Une télangiectasie hémorragique héréditaire révélée tardivement par une thrombose veineuse cérébrale : à propos d'un cas

30. Cryoablation of Soft Tissues Low-Flow Vascular Malformations: Clinical Outcomes and Safety

31. Prognostic factors in giant cell arteritis associated aortitis with PET/CT and CT angiography at diagnosis

33. Seven cases of hereditary haemorrhagic telangiectasia-like hepatic vascular abnormalities associated withEPHB4pathogenic variants

34. Semi-Quantitative [18F]FDG-PET/CT ROC-Analysis-Based Cut-Offs for Aortitis Definition in Giant Cell Arteritis

35. Women and Pregnancy in Thromboangiitis Obliterans

36. Aortite de l’artérite à cellules géantes : diagnostic, pronostic et traitement

37. Short- and Mid-Term Outcomes of Endovascular Stenting for the Treatment of Post-Thrombotic Syndrome due to Iliofemoral and Caval Occlusive Disease: A Multi-Centric Study from the French Society of Diagnostic and Interventional Cardiovascular Imaging (SFICV)

38. Large-vessel involvement is predictive of multiple relapses in giant cell arteritis

39. Association Between Preexisting Versus Newly Identified Atrial Fibrillation and Outcomes of Patients With Acute Pulmonary Embolism

40. Thoracic lymphadenopathies in diffuse systemic sclerosis: an observational study on 48 patients using computed tomography

41. [Vascular imaging in giant cell arteritis]

42. [Giant cell arteritis]

43. Predictive factors of venous recanalization in upper-extremity vein thrombosis

44. Spectrum and Outcome of Noninfectious Aortitis

45. Prevalence of post-thrombotic syndrome in a cohort of upper extremity vein thrombosis

46. Scalp Necrosis in Giant Cell Arteritis

47. A strobe multicenter descriptive study of 55 infectious aortitis

48. Vascular Presentation and Outcomes of Patients With Giant Cell Arteritis and Isolated Symptomatic Limb Involvement

49. Long-Term Outcome and Prognosis Factors of Isolated Aortitis

50. Épidémiologie des thromboses veineuses des membres supérieurs : étude rétrospective de 160 thromboses aiguës